"Cholecalciferol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivative of 7-dehydroxycholesterol formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. It differs from ERGOCALCIFEROL in having a single bond between C22 and C23 and lacking a methyl group at C24.
| Descriptor ID |
D002762
|
| MeSH Number(s) |
D04.210.500.247.222.159 D04.210.500.247.808.146 D04.210.500.812.768.196 D10.570.938.146
|
| Concept/Terms |
Cholecalciferol- Cholecalciferol
- Calciol
- (3 beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
- Vitamin D 3
- Vitamin D3
|
Below are MeSH descriptors whose meaning is more general than "Cholecalciferol".
Below are MeSH descriptors whose meaning is more specific than "Cholecalciferol".
This graph shows the total number of publications written about "Cholecalciferol" by people in this website by year, and whether "Cholecalciferol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cholecalciferol" by people in Profiles.
-
Vitamin D3 Supplementation Prior to Total Knee Arthroplasty: A?Randomized Controlled Trial. J Arthroplasty. 2023 06; 38(6S):S114-S119.
-
Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: Secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial. J Allergy Clin Immunol. 2016 08; 138(2):589-592.e2.
-
Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA. 2014 May; 311(20):2083-91.
-
Calcium plus vitamin D supplementation and the risk of postmenopausal weight gain. Arch Intern Med. 2007 May 14; 167(9):893-902.
-
Modulation of bone morphogenetic protein-2 and bone morphogenetic protein-4 gene expression in osteoblastic cell lines. Cell Mol Biol (Noisy-le-grand). 1998 Dec; 44(8):1237-46.